Both in Pharmaceuticals
NRX Pharmaceuticals vs Perspective Therapeutics
Over the past year NRXP returned −9.1% and CATX returned −62.7%; their daily moves had a correlation of 0.13.
NRXP −9.1% CATX −62.7%Growth of $1, one year, split-adjusted
| Metric | NRXP | CATX |
|---|---|---|
| Price | $2.49 | $0.8702 |
| Market cap | $107.8M | $99.3M |
| Today | +11.16% | −1.11% |
| 1 month | −15.3% | −63.1% |
| 6 months | −18.4% | −77.2% |
| Year to date | −8.1% | −68.4% |
| 1 year | −12.6% | −66.5% |
| Revenue growth (YoY) | — | −72.1% |
| Gross margin | 38.7% | 100.0% |
| Net margin | −1500.5% | −33069.1% |
| P/E (TTM) | — | — |
| Price / sales | 31.8× | 242.9× |
| Net cash | $26.3M | $235.3M |
| Dividend yield | — | — |
| Volatility (60d) | 61.5% | 117.1% |
| Short % of float | 29.3% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).